2018
AB0538 Increased body mass index may not be a risk factor for the development of lupus nephritis
Chock Y, Danve A, School of Medicine O, Petri M, Fu W. AB0538 Increased body mass index may not be a risk factor for the development of lupus nephritis. Annals Of The Rheumatic Diseases 2018, 77: 1425. DOI: 10.1136/annrheumdis-2018-eular.4524.Peer-Reviewed Original ResearchSystemic lupus erythematosusBody mass indexChronic kidney diseaseLow disease activityLupus nephritisSLE patientsDisease activityComplement levelsMass indexAvailable body mass indexBiopsy-proven lupus nephritisLow-grade inflammatory stateElevated body mass indexRetrospective cross-sectional studyFirst BMI measurementRisk of nephritisCategorical variablesHigher leptin levelsCross-sectional studyHigher complement levelsChi-square testLupus CohortCohort entryObese patientsACR criteria
2014
Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus—A case report
Danve A, Perry L, Deodhar A. Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus—A case report. Seminars In Arthritis And Rheumatism 2014, 44: 195-197. PMID: 25005336, DOI: 10.1016/j.semarthrit.2014.05.006.Peer-Reviewed Original ResearchConceptsActive systemic lupus erythematosusSystemic lupus erythematosusUse of belimumabCase reportLupus erythematosusPresence of SLEMild Ebstein's anomalyFirst case reportBelimumab usePregnancy RegistryActive lupusUnacceptable toxicityEbstein's anomalyUneventful coursePoor outcomeCaucasian womenBelimumabPregnancyModerate dosesMycophenolateErythematosusReportRelevant literatureAzathioprinePrednisone